疟疾药物市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00027669
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

预计 2023 年至 2031 年期间抗疟药物市场的复合年增长率为 8.5%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告按药物类别(奎宁、氯喹、氯胍、甲氟喹、乙胺嘧啶等)、分销(医院药房、零售药房、电子商务、其他分销渠道)和地域(北美、欧洲、亚太地区、中东和非洲以及南美和中美洲)对抗疟药市场进行细分。全球分析进一步细分为区域和主要国家。报告以美元为单位提供上述分析和细分的价值。

报告目的

Insight Partners 发布的《抗疟药物市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种商业利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

抗疟药物市场细分

 

药物类别

  • 奎宁
  • 氯喹
  • 氯胍
  • 甲氟喹
  • 乙胺嘧啶
  • 其他的

分配

  • 医院药房
  • 零售药店
  • 电子商务
  • 其他分销渠道

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

抗疟药物市场:战略洞察

Drugs For Malaria Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

抗疟药物市场增长动力

  • 疟疾发病率上升:根据世界卫生组织 (WHO) 的数据,疟疾是一种由疟原虫引起的急性发热性疾病,疟原虫通过受感染的雌性按蚊叮咬传播。疟疾是由 5 种寄生虫引起的,其中两种——恶性疟原虫和间日疟原虫——威胁最大。恶性疟原虫是最致命的疟疾寄生虫,也是非洲大陆分布最广的疟疾寄生虫。间日疟原虫是撒哈拉以南非洲以外大多数国家的主要疟疾寄生虫。
  • 疟疾病例不断增加:根据世卫组织最新的《2020 年世界疟疾报告》(WMR),2020 年全球报告了 2.41 亿疟疾病例,而 2019 年记录的疟疾病例为 2.27 亿。2020 年疟疾造成的死亡人数为 62 万,每年增加 69,000 人。其中约三分之二(47,000 人)的死亡是由于 COVID-19 大流行期间医疗服务中断造成的,其余三分之一的死亡(22,000 人)反映了世卫组织最近计算疟疾死亡率的方法的变化(不考虑 COVID-19 中断)
  • 尼日利亚和刚果病例增加:世卫组织的非洲地区继续占全球疟疾负担的极高份额。2020 年,全球 95% 的疟疾病例和 96% 的死亡病例发生在非洲;疟疾造成的总死亡人数中约 80% 发生在 5 岁以下儿童中。四个非洲国家——尼日利亚(31.9%)、刚果民主共和国(13.2%)、坦桑尼亚联合共和国(4.1%)和莫桑比克(3.8%)——占全球报告的疟疾相关死亡人数的近一半

抗疟药物市场未来趋势

  • 政府和私营部门的举措:疟疾宣传活动有助于提高人们对该疾病的认识,改善促进健康的行为,同时促进跨部门合作和社会支持。世卫组织协调全球疟疾规划 (GMP),作为其控制和根除疟疾的全球努力的一部分。该计划由世界卫生大会于 2015 年 5 月通过的“2016-2030 年全球疟疾技术战略”领导,并于 2021 年进一步重组。世卫组织每年将 4 月 25 日定为世界疟疾日,以强调世界各地疟疾社区团结起来,共同实现让世界摆脱疟疾的共同目标的集体能量和承诺。
  • 国家消除疟疾框架:2016 年,印度推出了第一个国家消除疟疾框架,有效期从 2016 年到 2030 年。2019 年,印度政府为 2003 年启动的国家媒介传播疾病控制计划筹集了超过 25% 的资金。该国还增加了对全球抗击疟疾基金的捐助。
  • 提高认识和教育:在美国,控制疟疾的努力主要通过总统疟疾倡议 (PMI) 进行,由美国全球疟疾协调员监督。根据全球卫生政策,美国计划在 2022 财年为疟疾控制和研究活动提供约 10 亿美元的资金。美国政府在 2021-2026 年 PMI 战略下的目标是控制疟疾并减少由疟疾造成的死亡,并制定消灭该疾病的长期目标。

抗疟药物市场机会

  • 新兴市场:一些政府正在采取措施提高人们的认识,并开展研究以开发新的抗疟药物和疫苗。根据世卫组织的数据,2019 年用于控制和消除疟疾的总资金达到约 30 亿美元;疟疾流行国家的政府共计贡献了总资金的 31%(约 9 亿美元)用于提高人们的认识和开发新疫苗。私营公司也在参与抗击疟疾的斗争,并大力投资研发活动。例如,2018 年,诺华公司投资了 1 亿多美元,以加强其到 2023 年的下一代治疗方法的研发活动。
  • 市场竞争加剧:缅甸有一项经全球基金批准的国家疟疾控制计划,预计到 2030 年将消除恶性疟原虫引起的疾病。该国的全民医疗保险包括通过显微镜或快速诊断测试 (RDT) 进行疟疾诊断以及提供青蒿素联合疗法 (ACT)。
  • 扩大新药和疫苗研发渠道:抗菌素耐药性威胁着公共卫生对许多疾病(如疟疾)的应对,而新药研发是克服这一挑战的最佳策略。因此,抗疟药物/疫苗研发渠道正变得越来越强大。公私合作伙伴关系正在加速疟疾治疗市场的研究活动,为市场增长创造有利可图的机会。例如,非营利组织“疟疾药物研发基金会”(MMV)正在与大量制药公司合作,通过开发新的治疗方案来减轻疟疾负担。

 

抗疟药物市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响抗疟药物市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的抗疟药物市场细分和地理位置。

Drugs For Malaria Market
  • 获取抗疟药物市场的区域特定数据

抗疟药物市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)8.5%
史料2021-2022
预测期2024-2031
涵盖的领域按药物类别
  • 奎宁
  • 氯喹
  • 氯胍
  • 甲氟喹
  • 乙胺嘧啶
  • 其他的
按分布
  • 医院药房
  • 零售药店
  • 电子商务
  • 其他分销渠道
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • Alvizia Healthcare Pvt.Ltd.
  • 拜耳公司
  • F. 霍夫曼-罗氏有限公司
  • 葛兰素史克公司
  • Ipca 实验室有限公司
  • 默克公司
  • 诺华公司
  • 辉瑞公司
  • 太阳制药工业有限公司

 

抗疟药物市场参与者密度:了解其对业务动态的影响

疟疾药物市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在抗疟药市场运营的主要公司有:

  1. Alvizia Healthcare Pvt.Ltd.
  2. 拜耳公司
  3. F. 霍夫曼-罗氏有限公司
  4. 葛兰素史克公司
  5. Ipca 实验室有限公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Drugs For Malaria Market

 

  • 了解抗疟药物市场的主要参与者概况

 

 

主要卖点

 

  • 全面覆盖:该报告全面涵盖了抗疟药物市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,关于抗疟药物市场的研究报告可以帮助引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is expected to witness the highest growth?

Asia Pacific region is expected to witness the highest growth during the forecast period

Which region is expected to witness the second highest growth in CAGR terms?

Middle East & Africa region is expected to witness a high growth rate in terms of CAGR after Asia Pacific region during the forecast period

What is the expected CAGR of the Drugs For Malaria Market?

The Drugs For Malaria Market is estimated to witness a CAGR of 8.5% from 2023 to 2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1.Alvizia Healthcare Pvt. Ltd.
2.Bayer AG
3.F. Hoffmann-La Roche Ltd
4.GlaxoSmithKline Plc
5.Ipca Laboratories Ltd.
6.Merck and Co., Inc
7.Novartis AG
8.Pfizer Inc.
9.Sun Pharmaceutical Industries Ltd.
10.Zydus Cadila.

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.